Mindful Health Solutions has named a new CEO. The San Francisco-based outpatient mental health provider announced on social media Tuesday that Meghan Herwehe has taken the corner office. The role was previously held by John Minahan, who was named to the role in 2021. The company was founded in 2007. It’s not clear when or […]
The behavioral health industry generally isn’t as entwined and reliant on the pharmaceutical industry as the rest of the health care industry. This creates a wide open space for innovative approaches to care. But there are powerful reasons behind why that space exists. Even so, as things stand today, the addiction treatment industry has the […]
The behavioral health market has exploded since the COVID-19 pandemic. Investors and provider organizations have paid premiums to grow their behavioral health footprint. But, industry insiders warn that the outpatient behavioral health industry is a tough business. The success stories in the space will likely be the companies keeping their operations tight and demonstrating improved […]
Outpatient mental health providers are looking for options to improve patient outcomes and add a new service line to their business. Transcranial magnetic stimulation (TMS) has come to the fore among a handful of alternative options that may help providers deliver additional value to patients and health plan partners. TMS is growing in popularity as […]
For all the hype, psychedelics such as MDMA or psilocybin won’t succeed as a treatment or service line without substantial clinical support within behavioral health organizations. As recent ketamine-provider stumbles demonstrate, simply establishing access to and attempting to scale singular forms of treatment tend to lead to failure. Further, such treatment-specific ventures fail to address […]
Ketamine therapy has a long way to go before it becomes a major part of the behavioral health industry. The high-profile stumbles at Field Trip Health & Wellness and Ketamine Wellness Center highlight the fraught environment the half-a-century-old drug faces in treating mental health at scale. It also illustrates the risk of moving too early […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
